Explore your preferred country in the list below:
Hong Kong
3
  • All
  • Psychiatry
  • Neurology
  • RECORDED

    Scientific Webinar - Recent Advances in The Management of Major Depressive Disorder

    This webinar will include a review of the advances in the management of MDD, with reference to the latest Canadian Network for Mood and Anxiety treatment clinical guidelines. Dr. Yip will also share three cases related to the use of antidepressants and the use of augmentation medications.

    WATCH NOW
    Yip Pui Lam
    Hong Kong
  • RECORDED

    Scientific Webinar - Use of Antidepressants in Primary Care Clinic

    In this webinar, Dr Law will share the experience of treating mood disorder in GP setting as well as experience in using vortioxetine. Case sharing and discuss how to start treating mood disorder in general practice.

    WATCH NOW
    Law Sai On
    Hong Kong
  • RECORDED

    Joint Scientific Webinar Crosstalk Between The GI Tract and The Brain

    Functional gastrointestinal disorders, also known as disorders of gut-brain interaction, is common among the adult population in Hong Kong. In this joint symposium, Prof. Justin Wu gives an overview on the bidirectional interaction between brain and gut, etiology, and treatment for these disorders. Prof. Tang Siu Wa discusses the role of inflammation in neuropsychiatric disorders with a perspective from traditional Chinese medicine.

    WATCH NOW
    Wu Che Yuen
    Hong Kong
    Siu Wa Tang
    Tang Siu Wa
    Hong Kong
  • RECORDED

    Highlights of 2021 MDS Congress & Case Discussions on Parkinson's Disease

    Our 3 speakers will be discussing on some key topics of MDS Virtual Congress 2021 in this webinar, these includes telemedicine clinic for Parkinson’s Disease, health disparities in Parkinson’s Disease and key updates on recent trials in Parkinson’s Disease. Our speakers will also attempt to share some best practices in the management of Parkinson's Disease through case sharing presentations in different stages of Parkinson's Disease.

    WATCH NOW
    Roongroj Bhidayasiri
    Thailand/Chair & Speaker
    Roland Dominic G. Jamora
    Philippines/Speaker
    Olivier Rascol
    France/Speaker
  • RECORDED

    Alzheimer's disease in 2021 & beyond

    Our two expert speakers – Dr Alireza Atri and Professor Miia Kivipelto – will take us through a brief history of Alzheimer’s disease to the modern-day view. In his Chair’s introduction, Dr Atri will briefly review 100 years of Alzheimer’s disease and research. Professor Kivipelto will then explore the challenges and consequences that the COVID-19 pandemic has brought to the care of patients with dementia. She will also consider future challenges, reviewing the epidemiology of Alzheimer’s disease, risk factors, and prevention strategies. Dr Atri will follow on with a contemporary view of treatment goals and will discuss aspects of multifactorial care.

    WATCH NOW
    Alireza Atri
    USA
    Miia Kivipelto
    Sweden
  • RECORDED

    COVID-19 & MDD: Current challenges and implications for clinical practice

    In the first episode of the series, we will focus on the impact of COVID-19 on patients with MDD; we will explore the common MDD symptoms reported during the global pandemic as well as the current challenges and long-term implications this will present for clinical practice. This episode will also address treatment options and considerations, including vortioxetine*, for patients with MDD during and post-pandemic. Professor Roger McIntyre, alongside Dr Mohammad Alsuwaidan and Dr Nina Scheweinfurth, will present recently published clinical data and share their own clinical experiences of managing MDD during the pandemic. *Vortioxetine – is indicated for the treatment of major depressive episodes in adults. For local prescribing information, please refer to the information you have received from your local Lundbeck representative for this event.

    WATCH NOW
    Roger McIntyre
    Roger S. McIntyre
    Canada
    Mohammad Alsuwaidan
    Mohammad Alsuwaidan
    Kuwait
    Nina Schweinfurth
    Nina Schweinfurth
    Switzerland
  • RECORDED

    Treatment on Major Depressive Disorder with Neurological Diseases

    Major depressive disorder (MDD) is often comorbid with neurological diseases such as post stroke, Alzheimer’s disease, Parkinson’s disease and contribute to the chronicity and severity of the disease. In this webinar, the role of antidepressants in managing MDD in these diseases will be presented by three experts in the field, as well as sharing of their practical experience in the decision making process on disease management via patient cases.

    WATCH NOW
    Pratap Chokka
    Pratap Chokka
    Canada
    Muzaffar Siddiqui
    Muzaffar Siddiqui
    Canada
    John Harisson
    John Harrison
    UK
  • RECORDED

    Masterclass Webinar Series - Antidepressant Treatment in Major Depressive Disorder

    Childhood trauma is associated with negative neurobiological, physical, behavioural, psychosocial and mental health effects, and can increase the risk of early onset, relapse and chronicity of MDD (major depressive disorder). Resilience has been linked to better outcomes in MDD, including a decreased risk of onset and relapse. This webinar will explore the social, emotional, cognitive and biological systems implicated in resilience. Importantly, the role of resilience for MDD patients with history of childhood trauma will be discussed, as well as tips on fostering resilience in clinical practice.

    WATCH NOW
    Roger McIntyre
    Roger S. McIntyre
    Canada
    Greg Mattingly
    Gregory Mattingly
    United States
  • RECORDED

    Masterclass Webinar Series - Anhedonia and Emotional Blunting in Major Depressive Disorder - Addressing Challenges in clinical management of MDD

    Anhedonia is an integral clinical feature of MDD (major depressive disorder) which is often neglected in clinical practice, defined by the lack of pleasure and motivation. Treatment with antidepressants could cause emotional blunting in some patients, which phenotypically overlaps with anhedonia. In this webinar, the challenges in clinical management of anhedonia and emotional blunting will be addressed, as well as the clinical approach and choice of optimal treatment options.

    WATCH NOW
    Roger McIntyre
    Roger S. McIntyre
    Canada
    Andrea Fagiolini
    Andrea Fagiolini
    Italy
  • RECORDED

    Masterclass Webinar Series - Treatment Adjustment in MDD - What does success look like?

    The majority of MDD (major depressive disorder) patients do not respond adequately to treatment, and a proper pharmacological management plan is key to ensuring full recovery. Switching, dose titration or augmentation of the current antidepressant are various options the clinician can undertake, and this webinar will include a debate on these options for maximal chance of recovery in MDD patients. In addition, the speakers will delve into the current treatment landscape of MDD, as well as the management of partial responders in MDD.

    WATCH NOW
    Andrea Fagiolini
    Andrea Fagiolini
    Italy
    Andrew Cutler
    Andrew J. Cutler
    United States
  • RECORDED

    Masterclass Webinar Series - Addressing functional challenges for patients with MDD

    The definition of treatment success in MDD (major depressive disorder) has evolved across the years to full functional recovery, where the patient returns back to a premorbid level of functioning. This requires the complete treatment of mood, cognitive and physical symptoms of MDD, and the choice of antidepressant is integral to full recovery. In this webinar, the speakers will address the challenges to achieving functional recovery for MDD patients, and present clinical evidence for vortioxetine as a treatment option, as well as share their practical experience.

    WATCH NOW
    Pratap Chokka
    Pratap Chokka
    Canada
    Iria Grande
    Iria Grande
    Spain
  • RECORDED

    Treatment Challenges in Managing GAD

    In this webinar, Dr Blier & Dr Cutler will be discussing the differences between normal anxiety & generalized anxiety disorder (GAD), the pharmacology treatments in GAD & also the challenges in managing GAD. Both experts will be sharing evidence based data and also their personal clinical experiences in this virtual event.

    WATCH NOW
    Pierre Blier
    Pierre Blier
    Canada
    Andrew Cutler
    Andrew J. Cutler
    United States
  • RECORDED

    Insights into current therapeutic management strategies in Parkinson’s Disease

    This scientific video seeks to review current diagnosis and treatment goals of Parkinson’s disease. The objective is to enhance and update the knowledge in management of Parkinson's disease - newer and wider utilization of therapeutic strategies will improve patient outcomes and pharmacological management of conditions that incorporates patients’ specific needs, experiences, and the professionals’ clinical judgement. The speaker will share the latest evidence-based medicine review of therapies to control symptom, improve quality of life, prevent disease progress, etc. Case studies will be used to discourse how to choose different options for effective management of different stages along the Parkinson’s disease trajectory

    WATCH NOW
    Susan Fox
    Prof Susan H Fox
    Canada
  • RECORDED

    The art of disclosing depression to your patients - Focus on depression in younger adults

    Do you struggle with disclosing mental disorders such as major depressive disorder (MDD) to your patients? How much do bedside manners really matter to the treatment plan? This session will discuss the trending topic of establishing the patient-doctor alliance and effective communication. In addition, the changing landscape of the treatment goal and management of MDD will be discussed, as well as practical advice via case studies of MDD management in active adults.

    WATCH NOW
    Pratap Chokka
    Pratap Chokka
    Canada
    Roger McIntyre
    Roger S. McIntyre
    Canada
  • RECORDED

    The art of disclosing depression to your patients - Focus on depression in older population

    Major depressive disorder (MDD) in the elderly is often accompanied with other chronic comorbidities. The treatment plan is hence complicated by polypharmacy with potential drug-drug interactions, which is further compounded by changing pharmacokinetics as we age. This session will delve into the management of MDD in elderly patients, with these important considerations in mind. The speakers will also discuss prescribing practicalities in the form of case studies in this population.

    WATCH NOW
    Pratap Chokka
    Pratap Chokka
    Canada
    Roger McIntyre
    Roger S. McIntyre
    Canada
  • RECORDED

    How Telemedicine and Antidepressants Improve the Management of Neurological Disorders

    Management of Parkinson's Disease may be challenging given the pandemic, limiting fact-to-face interactions between doctors and patients, telemedicine has come to the forefront in managing the disease. It will tackle how teleconsultations can affect clinical outcomes and patient's overall satisfaction. Several factors should be considered in choosing antidepressant for a patient and it needs to be individualized according to the patient's concomitant medication, metabolic profile, co-existing medical conditions, and the likelihood of drug-drug interactions.

    COMING SOON
    Arlene Ng
    Arlene Ng
    Philippines
    Siu Wa Tang
    Prof. Siu wa Tang
    Hong Kong
Indonesia
3
  • All
  • Psychiatry
  • Neurology
  • RECORDED
    Masterclass Webinar series

    COVID-19 & MDD: Current challenges and implications for clinical practice

    In the first episode of the series, we will focus on the impact of COVID-19 on patients with MDD; we will explore the common MDD symptoms reported during the global pandemic as well as the current challenges and long-term implications this will present for clinical practice. This episode will also address treatment options and considerations, including vortioxetine*, for patients with MDD during and post-pandemic. Professor Roger McIntyre, alongside Dr Mohammad Alsuwaidan and Dr Nina Scheweinfurth, will present recently published clinical data and share their own clinical experiences of managing MDD during the pandemic. *Vortioxetine – is indicated for the treatment of major depressive episodes in adults. For local prescribing information, please refer to the information you have received from your local Lundbeck representative for this event.

    WATCH NOW
    Roger McIntyre
    Roger S. McIntyre
    Canada
    Mohammad Alsuwaidan
    Mohammad Alsuwaidan
    Kuwait
    Nina Schweinfurth
    Nina Schweinfurth
    Switzerland
  • RECORDED

    Treatment on Major Depressive Disorder with Neurological Diseases

    Major depressive disorder (MDD) is often comorbid with neurological diseases such as post stroke, Alzheimer’s disease, Parkinson’s disease and contribute to the chronicity and severity of the disease. In this webinar, the role of antidepressants in managing MDD in these diseases will be presented by three experts in the field, as well as sharing of their practical experience in the decision making process on disease management via patient cases.

    WATCH NOW
    Pratap Chokka
    Pratap Chokka
    Canada
    Muzaffar Siddiqui
    Muzaffar Siddiqui
    Canada
    John Harisson
    John Harrison
    UK
  • RECORDED

    Treatment Challenges in Managing GAD

    In this webinar, Dr Blier & Dr Cutler will be discussing the differences between normal anxiety & generalized anxiety disorder (GAD), the pharmacology treatments in GAD & also the challenges in managing GAD. Both experts will be sharing evidence based data and also their personal clinical experiences in this virtual event.

    WATCH NOW
    Pierre Blier
    Pierre Blier
    Canada
    Andrew Cutler
    Andrew J. Cutler
    United States
Malaysia
3
  • All
  • Psychiatry
  • Neurology
  • RECORDED

    Alzheimer's disease in 2021 & beyond

    Our two expert speakers – Dr Alireza Atri and Professor Miia Kivipelto – will take us through a brief history of Alzheimer’s disease to the modern-day view. In his Chair’s introduction, Dr Atri will briefly review 100 years of Alzheimer’s disease and research. Professor Kivipelto will then explore the challenges and consequences that the COVID-19 pandemic has brought to the care of patients with dementia. She will also consider future challenges, reviewing the epidemiology of Alzheimer’s disease, risk factors, and prevention strategies. Dr Atri will follow on with a contemporary view of treatment goals and will discuss aspects of multifactorial care.

    WATCH NOW
    Alireza Atri
    USA
    Miia Kivipelto
    Sweden
  • RECORDED

    COVID-19 & MDD: Current challenges and implications for clinical practice

    In the first episode of the series, we will focus on the impact of COVID-19 on patients with MDD; we will explore the common MDD symptoms reported during the global pandemic as well as the current challenges and long-term implications this will present for clinical practice. This episode will also address treatment options and considerations, including vortioxetine*, for patients with MDD during and post-pandemic. Professor Roger McIntyre, alongside Dr Mohammad Alsuwaidan and Dr Nina Scheweinfurth, will present recently published clinical data and share their own clinical experiences of managing MDD during the pandemic. *Vortioxetine – is indicated for the treatment of major depressive episodes in adults. For local prescribing information, please refer to the information you have received from your local Lundbeck representative for this event.

    WATCH NOW
    Roger McIntyre
    Roger S. McIntyre
    Canada
    Mohammad Alsuwaidan
    Mohammad Alsuwaidan
    Kuwait
    Nina Schweinfurth
    Nina Schweinfurth
    Switzerland
  • RECORDED

    Towards a paradigm shift in treatment of bipolar disorder

    Bipolar Disorder Is an episodeic, lifelong illness with a variable course. The high recurrent nature of the disease can be very difficult to manage. Poor adherence to treatment is a significant problem to the management of the disease thus resulting in suboptimal outcome. In conjunction with World Bipolar Dat, Prof Eduard Vieta will be sharing the role of long-acting injectable antipsychotic in the management of bipolar disorder alongside with Prof Ahmad Hatim, sharing his clinical experience. This webinar aims to address the unmet needs in the treatment of bipolar disorder.

    WATCH NOW
    Michael Ang
    Michael Ang
    Malaysia
    Eduard Vieta
    Eduard Vieta
    Spain
    Ahmad Hatim Sulaiman
    Ahmad Hatim Sulaiman
    Malaysia
  • RECORDED

    Treatment duration in Bipolar Disorder & Schizophrenia

    Schizophrenia and bipolar disorder are both mental illnesses that are commonly associated with impairments in social and occupational functioning. Long-term effective treatments that can reduce the relapse rate in these diseases is one of the keys to treatment success. In this webinar, it addresses the need for long-term continuous treatment and the role of long-acting injectables in both schizophrenia and bipolar disorder.There is also an interactive discussion on the topic during the Q&A session

    WATCH NOW
    Amer Siddiq
    Amer Siddiq
    Malaysia
    Andrea Fagiolini
    Andrea Fagiolini
    Italy
  • RECORDED

    Treatment on Major Depressive Disorder with Neurological Diseases

    Major depressive disorder (MDD) is often comorbid with neurological diseases such as post stroke, Alzheimer’s disease, Parkinson’s disease and contribute to the chronicity and severity of the disease. In this webinar, the role of antidepressants in managing MDD in these diseases will be presented by three experts in the field, as well as sharing of their practical experience in the decision making process on disease management via patient cases.

    WATCH NOW
    Pratap Chokka
    Pratap Chokka
    Canada
    Muzaffar Siddiqui
    Muzaffar Siddiqui
    Canada
    John Harisson
    John Harrison
    UK
  • RECORDED

    Masterclass Webinar Series - Antidepressant Treatment in Major Depressive Disorder

    Childhood trauma is associated with negative neurobiological, physical, behavioural, psychosocial and mental health effects, and can increase the risk of early onset, relapse and chronicity of MDD (major depressive disorder). Resilience has been linked to better outcomes in MDD, including a decreased risk of onset and relapse. This webinar will explore the social, emotional, cognitive and biological systems implicated in resilience. Importantly, the role of resilience for MDD patients with history of childhood trauma will be discussed, as well as tips on fostering resilience in clinical practice.

    WATCH NOW
    Roger McIntyre
    Roger S. McIntyre
    Canada
    Greg Mattingly
    Gregory Mattingly
    United States
  • RECORDED

    Masterclass Webinar Series - Anhedonia and Emotional Blunting in Major Depressive Disorder - Addressing Challenges in clinical management of MDD

    Anhedonia is an integral clinical feature of MDD (major depressive disorder) which is often neglected in clinical practice, defined by the lack of pleasure and motivation. Treatment with antidepressants could cause emotional blunting in some patients, which phenotypically overlaps with anhedonia. In this webinar, the challenges in clinical management of anhedonia and emotional blunting will be addressed, as well as the clinical approach and choice of optimal treatment options.

    WATCH NOW
    Roger McIntyre
    Roger S. McIntyre
    Canada
    Andrea Fagiolini
    Andrea Fagiolini
    Italy
  • RECORDED

    THINK Depression Part 1: Connecting with your patients living with depression

    Interested to find out what are the challenges faced by general practitioner when it comes to treating depression? This session will discuss on how to disclose depression to your patients, recommended bedside manners, setting the foundation & putting it into practice. The changing landscape of treatment goal will also be discussed. The speakers will also discuss on communication being the key to understand patients experience & functional recovery being the aim in the treatment of depression.

    WATCH NOW
    Beatrice Ng Andrew
    Beatrice Ng Andrew
    Malaysia
    Yee Kok Wah
    Yee Kok Wah
    Malaysia
  • RECORDED

    THINK Depression Part 2: Understanding co-morbid depression & anxiety

    This session will discuss the hurdles in managing anxiety. How do we differentiate depression and anxiety? What are the symptoms, assessment tools and treatment choices available? We will also be discussing the role of the general practitioner in treating depression and co-morbid anxiety.

    WATCH NOW
    Prof Philip George
    Malaysia
  • RECORDED

    THINK Depression Part 3: Battling Depression - The road to functional recovery

    Depression is a heterogeneous disease. It is more than just low mood, it also affects your body and the way you think. What will be the treatment goal when it comes to treating depression? What will be our role as front-liners during such a pandemic to battle depression?

    WATCH NOW
    Beatrice Ng Andrew
    Beatrice Ng Andrew
    Malaysia
    Michael Ang
    Michael Ang
    Malaysia
  • RECORDED

    Explore the new possibilities - Part 1 Schizophrenia

    Schizophrenia is a progressively debilitating mental disorder comprising positive, negative and cognitive symptoms. The course and outcome of schizophrenia can be very different and shaped by accurate diagnosis and well-chosen medications. Presently, multiple agents are available for the treatment of schizophrenia; however, the majority do not address negative and cognitive symptoms. Thus, it remains as one of the unmet needs in the treatment of schizophrenia. Introducing the new treatment option for schizophrenia to address not only positive symptoms but also negative and cognitive symptoms to help patients to be functioning and integrate back to society again.

    WATCH NOW
    Greg Mattingly
    Gregory Mattingly
    United States
  • RECORDED

    Explore the new possibilities - Part 2 Adjunctive Therapy in MDD

    Major depressive disorder (MDD) is a multifaceted condition with emotional, cognitive and physical symptoms that affect psychosocial functioning and quality of life. The best treatment outcome for a patient with MDD is a return to an optimal level of functioning, which may include the ability to maintain a job, build and retain relationships and interact with others. However, despite the availabiliity of different classes of antidepressants, many patients with MDD still experience an inadequate response to antidepressants, prolonging loss of social functioning and sense of well-being. Therefore, the role of an adjunctive therapy in MDD is needed to help patients achieve their full recovery and return to their functioning again.

    WATCH NOW
    Greg Mattingly
    Gregory Mattingly
    United States
Pakistan
3
  • All
  • Psychiatry
  • Neurology
  • RECORDED

    COVID-19 & MDD: Current challenges and implications for clinical practice

    In the first episode of the series, we will focus on the impact of COVID-19 on patients with MDD; we will explore the common MDD symptoms reported during the global pandemic as well as the current challenges and long-term implications this will present for clinical practice. This episode will also address treatment options and considerations, including vortioxetine*, for patients with MDD during and post-pandemic. Professor Roger McIntyre, alongside Dr Mohammad Alsuwaidan and Dr Nina Scheweinfurth, will present recently published clinical data and share their own clinical experiences of managing MDD during the pandemic. *Vortioxetine – is indicated for the treatment of major depressive episodes in adults. For local prescribing information, please refer to the information you have received from your local Lundbeck representative for this event.

    WATCH NOW
    Roger McIntyre
    Roger S. McIntyre
    Canada
    Mohammad Alsuwaidan
    Mohammad Alsuwaidan
    Kuwait
    Nina Schweinfurth
    Nina Schweinfurth
    Switzerland
  • RECORDED

    Treatment on Major Depressive Disorder with Neurological Diseases

    Major depressive disorder (MDD) is often comorbid with neurological diseases such as post stroke, Alzheimer’s disease, Parkinson’s disease and contribute to the chronicity and severity of the disease. In this webinar, the role of antidepressants in managing MDD in these diseases will be presented by three experts in the field, as well as sharing of their practical experience in the decision making process on disease management via patient cases.

    WATCH NOW
    Pratap Chokka
    Pratap Chokka
    Canada
    Muzaffar Siddiqui
    Muzaffar Siddiqui
    Canada
    John Harisson
    John Harrison
    UK
  • RECORDED

    Treatment Challenges in Managing GAD

    In this webinar, Dr Blier & Dr Cutler will be discussing the differences between normal anxiety & generalized anxiety disorder (GAD), the pharmacology treatments in GAD & also the challenges in managing GAD. Both experts will be sharing evidence based data and also their personal clinical experiences in this virtual event.

    WATCH NOW
    Pierre Blier
    Pierre Blier
    Canada
    Andrew Cutler
    Andrew J. Cutler
    United States
Philippines
3
  • All
  • Psychiatry
  • Neurology
  • RECORDED

    COVID-19 & MDD: Current challenges and implications for clinical practice

    In the first episode of the series, we will focus on the impact of COVID-19 on patients with MDD; we will explore the common MDD symptoms reported during the global pandemic as well as the current challenges and long-term implications this will present for clinical practice. This episode will also address treatment options and considerations, including vortioxetine*, for patients with MDD during and post-pandemic. Professor Roger McIntyre, alongside Dr Mohammad Alsuwaidan and Dr Nina Scheweinfurth, will present recently published clinical data and share their own clinical experiences of managing MDD during the pandemic. *Vortioxetine – is indicated for the treatment of major depressive episodes in adults. For local prescribing information, please refer to the information you have received from your local Lundbeck representative for this event.

    WATCH NOW
    Roger McIntyre
    Roger S. McIntyre
    Canada
    Mohammad Alsuwaidan
    Mohammad Alsuwaidan
    Kuwait
    Nina Schweinfurth
    Nina Schweinfurth
    Switzerland
  • RECORDED

    The Implications of Depression in GAD and Post-stroke Patients

    Often associated with symptoms overlap, Generalized Anxiety Disorder (GAD) with Major Depressive Disorder (MDD) is one of the most common anxiety-mood comorbidity types. With the continuous rise of pandemic-related mental health issues, proper management of both disorders is imperative. The first topic will discuss the challenges associated with the diagnosis and treatment of patients with both GAD and MDD, done through a case presentation to further relate it to one’s overall well-being. Going further into the implications of depression in the patient's quality of life, the second session focuses on Post-Stroke Depression (PSD) as it is often associated with poorer functional outcomes and increased risk of mortality. This presentation highlights the prevalence and impact of this comorbidity, with the objective to develop an approach for the assessment and management of Post-Stroke Depressed patients.

    WATCH NOW
    Jannel Gatlabayan Cleto
    Jannel Gatlabayan-Cleto
    Philippines
    Gerardo Salazar
    Gerardo Salazar
    Philippines
  • RECORDED

    Zooming In: The Impact of COVID-19 Quarantine in Managing BPSD

    With the year-long quarantine still in place, the more common behavioral and psychological symptoms of dementia (such as irritability, apathy or agitation) may either worsen or start to manifest, negatively affecting the quality of life of both the patient and the caregiver. In this webinar, the management of these symptoms in the midst of these restrictions will be discussed through patient case presentations, with a zoom in on depression in patients with Alzheimer's Disease.

    WATCH NOW
    Encarnita Raya-Ampil
    Encarnita Raya-Ampil
    Philippines
    Pia Natalya Reyes-Sia
    Pia Natalya Reyes-Sia
    Philippines
  • RECORDED

    Masterclass Webinar Series - Antidepressant Treatment in Major Depressive Disorder

    Childhood trauma is associated with negative neurobiological, physical, behavioural, psychosocial and mental health effects, and can increase the risk of early onset, relapse and chronicity of MDD (major depressive disorder). Resilience has been linked to better outcomes in MDD, including a decreased risk of onset and relapse. This webinar will explore the social, emotional, cognitive and biological systems implicated in resilience. Importantly, the role of resilience for MDD patients with history of childhood trauma will be discussed, as well as tips on fostering resilience in clinical practice.

    WATCH NOW
    Roger McIntyre
    Roger S. McIntyre
    Canada
    Greg Mattingly
    Gregory Mattingly
    United States
  • RECORDED

    Masterclass Webinar Series - Anhedonia and Emotional Blunting in Major Depressive Disorder - Addressing Challenges in clinical management of MDD

    Anhedonia is an integral clinical feature of MDD (major depressive disorder) which is often neglected in clinical practice, defined by the lack of pleasure and motivation. Treatment with antidepressants could cause emotional blunting in some patients, which phenotypically overlaps with anhedonia. In this webinar, the challenges in clinical management of anhedonia and emotional blunting will be addressed, as well as the clinical approach and choice of optimal treatment options.

    WATCH NOW
    Roger McIntyre
    Roger S. McIntyre
    Canada
    Andrea Fagiolini
    Andrea Fagiolini
    Italy
  • RECORDED

    Masterclass Webinar Series - Treatment Adjustment in MDD - What does success look like?

    The majority of MDD (major depressive disorder) patients do not respond adequately to treatment, and a proper pharmacological management plan is key to ensuring full recovery. Switching, dose titration or augmentation of the current antidepressant are various options the clinician can undertake, and this webinar will include a debate on these options for maximal chance of recovery in MDD patients. In addition, the speakers will delve into the current treatment landscape of MDD, as well as the management of partial responders in MDD.

    WATCH NOW
    Andrea Fagiolini
    Andrea Fagiolini
    Italy
    Andrew Cutler
    Andrew J. Cutler
    United States
  • RECORDED

    Masterclass Webinar Series - Addressing functional challenges for patients with MDD

    The definition of treatment success in MDD (major depressive disorder) has evolved across the years to full functional recovery, where the patient returns back to a premorbid level of functioning. This requires the complete treatment of mood, cognitive and physical symptoms of MDD, and the choice of antidepressant is integral to full recovery. In this webinar, the speakers will address the challenges to achieving functional recovery for MDD patients, and present clinical evidence for vortioxetine as a treatment option, as well as share their practical experience.

    WATCH NOW
    Pratap Chokka
    Pratap Chokka
    Canada
    Iria Grande
    Iria Grande
    Spain
  • RECORDED

    MDD and Anxiety: Meeting mental health challenges in this pandemic

    The pandemic has further increased depression and anxiety cases worldwide. With October as the World Mental Health Month and with this year’s global theme as “Mental Health for All”, concrete steps are needed in order to address the new challenges presented by COVID-19. Pharmacological treatment is one of these options. The role of resilience in MDD and managing pandemic-triggered anxiety will be the main discussion points in this webinar. Case presentations will also be used to highlight their implications in actual clinical practice.

    WATCH NOW
    Monina Garduno-Cruz
    Monina Garduño-Cruz
    Philippines
    Roger McIntyre
    Roger S. McIntyre
    Canada
  • RECORDED

    The Psychiatric Emergency: Managing Agitated Patients

    Agitation is one of the most common psychiatric emergencies seen in patients suffering from mental illnesses. The anxiety and isolation caused by the pandemic may also trigger this behavior. This webinar will focus on the different approaches in effectively managing agitated patients based on behavior severity. Relevant clinical guidelines on the topic will also be discussed.

    WATCH NOW
    Fareda Fatima Flores
    Fareda Fatima Flores
    Philippines
    Myra Dee Lopez-Roces
    Myra Dee Lopex-Roces
    Philippines
  • RECORDED

    How Telemedicine and Antidepressants Improve the Management of Neurological Disorders

    Management of Parkinson's Disease may be challenging given the pandemic, limiting fact-to-face interactions between doctors and patients, telemedicine has come to the forefront in managing the disease. It will tackle how teleconsultations can affect clinical outcomes and patient's overall satisfaction. Several factors should be considered in choosing antidepressant for a patient and it needs to be individualized according to the patient's concomitant medication, metabolic profile, co-existing medical conditions, and the likelihood of drug-drug interactions.

    COMING SOON
    Arlene Ng
    Arlene Ng
    Philippines
    Siu Wa Tang
    Prof. Siu wa Tang
    Hong Kong
Singapore
3
  • All
  • Psychiatry
  • Neurology
  • RECORDED

    Tailoring Treatment for Depression: A focus on patients with Anhedonia or Emotional Blunting

    In this session, the discussion will be focusing on the differences and similarities between anhedonia and emotional blunting, their impact on patients’ lives and how to identify them in clinical practice. New data will be shared on the effects of vortioxetine on anhedonia as well as from the COMPLETE study which focused on emotional blunting. The clinical implications of these studies and real-world observations will also be discussed.

    WATCH NOW
    Andrea Fagiolini
    Andrea Fagiolini
    Italy
  • RECORDED

    Measure Outcome, Redefine Expectation in MDD

    Patient vocabulary can sometimes include terms like a lack of “feeling like themselves again” or “being able to actually be around people for the first time. Prof Roueen Rafeyan is a practicing psychiatrist in Chicago, Illinois where he is Board certified in Psychiatry, Neurology and Addiction medicine, and was chosen as one of the Top Psychiatrist in the Nation by consumer Report 2007. He was one of the youngest psychiatrists to be given the Distinguished Fellow designation by American Psychiatric Association 2010. In this talk, Prof Rafeyan will speak on Measure Outcomes, and Redefine Expectations for patients to get MORE out of life.

    WATCH NOW
    Roueen Rafeyan
    Prof Roueen Rafeyan
    United States
  • RECORDED
    Masterclass Webinar series

    COVID-19 & MDD: Current challenges and implications for clinical practice

    In the first episode of the series, we will focus on the impact of COVID-19 on patients with MDD; we will explore the common MDD symptoms reported during the global pandemic as well as the current challenges and long-term implications this will present for clinical practice. This episode will also address treatment options and considerations, including vortioxetine*, for patients with MDD during and post-pandemic. Professor Roger McIntyre, alongside Dr Mohammad Alsuwaidan and Dr Nina Scheweinfurth, will present recently published clinical data and share their own clinical experiences of managing MDD during the pandemic. *Vortioxetine – is indicated for the treatment of major depressive episodes in adults. For local prescribing information, please refer to the information you have received from your local Lundbeck representative for this event.

    WATCH NOW
    Roger McIntyre
    Roger S. McIntyre
    Canada
    Mohammad Alsuwaidan
    Mohammad Alsuwaidan
    Kuwait
    Nina Schweinfurth
    Nina Schweinfurth
    Switzerland
  • RECORDED

    Treatment on Major Depressive Disorder with Neurological Diseases

    Major depressive disorder (MDD) is often comorbid with neurological diseases such as post stroke, Alzheimer’s disease, Parkinson’s disease and contribute to the chronicity and severity of the disease. In this webinar, the role of antidepressants in managing MDD in these diseases will be presented by three experts in the field, as well as sharing of their practical experience in the decision making process on disease management via patient cases.

    WATCH NOW
    Pratap Chokka
    Pratap Chokka
    Canada
    Muzaffar Siddiqui
    Muzaffar Siddiqui
    Canada
    John Harisson
    John Harrison
    UK
  • RECORDED

    Aripiprazole LAI on the treatment of early phases schizophrenia

    Treatment adherence is one of the key challenges in the management in schizophrenia. This webinar aims to share two case studies from Taiwan and Turkey on the role of monthly treatment in the early phases of schizophrenia.; we are also expecting to have an interactive Q&A session to discuss the practicality on pharmacology treatment in schizophrenia.

    COMING SOON
    Paul Lee
    Paul Lee
    Philippines
    Chiu Nan Ying
    Chiu Nan Ying
    Taiwan
    Neslihan Akkisi Kumsar
    Neslihan Akkisi Kumsar
    Turkey
  • RECORDED

    Masterclass Webinar Series - Antidepressant Treatment in Major Depressive Disorder

    Childhood trauma is associated with negative neurobiological, physical, behavioural, psychosocial and mental health effects, and can increase the risk of early onset, relapse and chronicity of MDD (major depressive disorder). Resilience has been linked to better outcomes in MDD, including a decreased risk of onset and relapse. This webinar will explore the social, emotional, cognitive and biological systems implicated in resilience. Importantly, the role of resilience for MDD patients with history of childhood trauma will be discussed, as well as tips on fostering resilience in clinical practice.

    WATCH NOW
    Roger McIntyre
    Roger S. McIntyre
    Canada
    Greg Mattingly
    Gregory Mattingly
    United States
  • RECORDED

    Masterclass Webinar Series - Anhedonia and Emotional Blunting in Major Depressive Disorder - Addressing Challenges in clinical management of MDD

    Anhedonia is an integral clinical feature of MDD (major depressive disorder) which is often neglected in clinical practice, defined by the lack of pleasure and motivation. Treatment with antidepressants could cause emotional blunting in some patients, which phenotypically overlaps with anhedonia. In this webinar, the challenges in clinical management of anhedonia and emotional blunting will be addressed, as well as the clinical approach and choice of optimal treatment options.

    WATCH NOW
    Roger McIntyre
    Roger S. McIntyre
    Canada
    Andrea Fagiolini
    Andrea Fagiolini
    Italy
  • RECORDED

    Masterclass Webinar Series - Treatment Adjustment in MDD - What does success look like?

    The majority of MDD (major depressive disorder) patients do not respond adequately to treatment, and a proper pharmacological management plan is key to ensuring full recovery. Switching, dose titration or augmentation of the current antidepressant are various options the clinician can undertake, and this webinar will include a debate on these options for maximal chance of recovery in MDD patients. In addition, the speakers will delve into the current treatment landscape of MDD, as well as the management of partial responders in MDD.

    WATCH NOW
    Andrea Fagiolini
    Andrea Fagiolini
    Italy
    Andrew Cutler
    Andrew J. Cutler
    United States
  • RECORDED

    Masterclass Webinar Series - Addressing functional challenges for patients with MDD

    The definition of treatment success in MDD (major depressive disorder) has evolved across the years to full functional recovery, where the patient returns back to a premorbid level of functioning. This requires the complete treatment of mood, cognitive and physical symptoms of MDD, and the choice of antidepressant is integral to full recovery. In this webinar, the speakers will address the challenges to achieving functional recovery for MDD patients, and present clinical evidence for vortioxetine as a treatment option, as well as share their practical experience.

    WATCH NOW
    Pratap Chokka
    Pratap Chokka
    Canada
    Iria Grande
    Iria Grande
    Spain
  • RECORDED

    Treatment Challenges in Managing GAD

    In this webinar, Dr Blier & Dr Cutler will be discussing the differences between normal anxiety & generalized anxiety disorder (GAD), the pharmacology treatments in GAD & also the challenges in managing GAD. Both experts will be sharing evidence based data and also their personal clinical experiences in this virtual event.

    WATCH NOW
    Pierre Blier
    Pierre Blier
    Canada
    Andrew Cutler
    Andrew J. Cutler
    United States
  • RECORDED

    Insights into current therapeutic management strategies in Parkinson’s Disease

    This scientific video seeks to review current diagnosis and treatment goals of Parkinson’s disease. The objective is to enhance and update the knowledge in management of Parkinson's disease - newer and wider utilization of therapeutic strategies will improve patient outcomes and pharmacological management of conditions that incorporates patients’ specific needs, experiences, and the professionals’ clinical judgement. The speaker will share the latest evidence-based medicine review of therapies to control symptom, improve quality of life, prevent disease progress, etc. Case studies will be used to discourse how to choose different options for effective management of different stages along the Parkinson’s disease trajectory

    WATCH NOW
    Susan Fox
    Prof Susan H Fox
    Canada
Taiwan
3
  • All
  • Psychiatry
  • Neurology
  • RECORDED

    Treatment on Major Depressive Disorder with Neurological Diseases

    Major depressive disorder (MDD) is often comorbid with neurological diseases such as post stroke, Alzheimer’s disease, Parkinson’s disease and contribute to the chronicity and severity of the disease. In this webinar, the role of antidepressants in managing MDD in these diseases will be presented by three experts in the field, as well as sharing of their practical experience in the decision making process on disease management via patient cases.

    WATCH NOW
    Pratap Chokka
    Pratap Chokka
    Canada
    Muzaffar Siddiqui
    Muzaffar Siddiqui
    Canada
    John Harisson
    John Harrison
    UK
  • RECORDED

    Masterclass Webinar Series - Antidepressant Treatment in Major Depressive Disorder

    Childhood trauma is associated with negative neurobiological, physical, behavioural, psychosocial and mental health effects, and can increase the risk of early onset, relapse and chronicity of MDD (major depressive disorder). Resilience has been linked to better outcomes in MDD, including a decreased risk of onset and relapse. This webinar will explore the social, emotional, cognitive and biological systems implicated in resilience. Importantly, the role of resilience for MDD patients with history of childhood trauma will be discussed, as well as tips on fostering resilience in clinical practice.

    WATCH NOW
    Roger McIntyre
    Roger S. McIntyre
    Canada
    Greg Mattingly
    Gregory Mattingly
    United States
  • RECORDED

    Masterclass Webinar Series - Treatment Adjustment in MDD - What does success look like?

    The majority of MDD (major depressive disorder) patients do not respond adequately to treatment, and a proper pharmacological management plan is key to ensuring full recovery. Switching, dose titration or augmentation of the current antidepressant are various options the clinician can undertake, and this webinar will include a debate on these options for maximal chance of recovery in MDD patients. In addition, the speakers will delve into the current treatment landscape of MDD, as well as the management of partial responders in MDD.

    WATCH NOW
    Andrea Fagiolini
    Andrea Fagiolini
    Italy
    Andrew Cutler
    Andrew J. Cutler
    United States
  • RECORDED

    Treatment Challenges in Managing GAD

    In this webinar, Dr Blier & Dr Cutler will be discussing the differences between normal anxiety & generalized anxiety disorder (GAD), the pharmacology treatments in GAD & also the challenges in managing GAD. Both experts will be sharing evidence based data and also their personal clinical experiences in this virtual event.

    WATCH NOW
    Pierre Blier
    Pierre Blier
    Canada
    Andrew Cutler
    Andrew J. Cutler
    United States
Thailand
3
  • All
  • Psychiatry
  • Neurology
  • RECORDED

    Treatment on Major Depressive Disorder with Neurological Diseases

    Major depressive disorder (MDD) is often comorbid with neurological diseases such as post stroke, Alzheimer’s disease, Parkinson’s disease and contribute to the chronicity and severity of the disease. In this webinar, the role of antidepressants in managing MDD in these diseases will be presented by three experts in the field, as well as sharing of their practical experience in the decision making process on disease management via patient cases.

    WATCH NOW
    Pratap Chokka
    Pratap Chokka
    Canada
    Muzaffar Siddiqui
    Muzaffar Siddiqui
    Canada
    John Harisson
    John Harrison
    UK
  • RECORDED

    TSAD WFH #9: Choosing the First Choice; MDD Symptoms & Subtypes

    This Webinar is covers the topics as below: • Vortioxetine; a multimodal antidepressant • MDD and its heterogeneity • MDD symptoms and their specific treatments • MDD subtypes and their specific treatments

    WATCH NOW
    Paul Thisayakorn
    Thailand
  • RECORDED

    Masterclass Webinar Series - Antidepressant Treatment in Major Depressive Disorder

    Childhood trauma is associated with negative neurobiological, physical, behavioural, psychosocial and mental health effects, and can increase the risk of early onset, relapse and chronicity of MDD (major depressive disorder). Resilience has been linked to better outcomes in MDD, including a decreased risk of onset and relapse. This webinar will explore the social, emotional, cognitive and biological systems implicated in resilience. Importantly, the role of resilience for MDD patients with history of childhood trauma will be discussed, as well as tips on fostering resilience in clinical practice.

    WATCH NOW
    Roger McIntyre
    Roger S. McIntyre
    Canada
    Greg Mattingly
    Gregory Mattingly
    United States
  • RECORDED

    Masterclass Webinar Series - Anhedonia and Emotional Blunting in Major Depressive Disorder - Addressing Challenges in clinical management of MDD

    Anhedonia is an integral clinical feature of MDD (major depressive disorder) which is often neglected in clinical practice, defined by the lack of pleasure and motivation. Treatment with antidepressants could cause emotional blunting in some patients, which phenotypically overlaps with anhedonia. In this webinar, the challenges in clinical management of anhedonia and emotional blunting will be addressed, as well as the clinical approach and choice of optimal treatment options.

    WATCH NOW
    Roger McIntyre
    Roger S. McIntyre
    Canada
    Andrea Fagiolini
    Andrea Fagiolini
    Italy
  • RECORDED

    Masterclass Webinar Series - Treatment Adjustment in MDD - What does success look like?

    The majority of MDD (major depressive disorder) patients do not respond adequately to treatment, and a proper pharmacological management plan is key to ensuring full recovery. Switching, dose titration or augmentation of the current antidepressant are various options the clinician can undertake, and this webinar will include a debate on these options for maximal chance of recovery in MDD patients. In addition, the speakers will delve into the current treatment landscape of MDD, as well as the management of partial responders in MDD.

    WATCH NOW
    Andrea Fagiolini
    Andrea Fagiolini
    Italy
    Andrew Cutler
    Andrew J. Cutler
    United States
  • RECORDED

    Masterclass Webinar Series - Addressing functional challenges for patients with MDD

    The definition of treatment success in MDD (major depressive disorder) has evolved across the years to full functional recovery, where the patient returns back to a premorbid level of functioning. This requires the complete treatment of mood, cognitive and physical symptoms of MDD, and the choice of antidepressant is integral to full recovery. In this webinar, the speakers will address the challenges to achieving functional recovery for MDD patients, and present clinical evidence for vortioxetine as a treatment option, as well as share their practical experience.

    WATCH NOW
    Pratap Chokka
    Pratap Chokka
    Canada
    Iria Grande
    Iria Grande
    Spain
  • RECORDED

    Treatment Challenges in Managing GAD

    In this webinar, Dr Blier & Dr Cutler will be discussing the differences between normal anxiety & generalized anxiety disorder (GAD), the pharmacology treatments in GAD & also the challenges in managing GAD. Both experts will be sharing evidence based data and also their personal clinical experiences in this virtual event.

    WATCH NOW
    Pierre Blier
    Pierre Blier
    Canada
    Andrew Cutler
    Andrew J. Cutler
    United States
  • RECORDED

    The art of disclosing depression to your patients - Focus on depression in younger adults

    Do you struggle with disclosing mental disorders such as major depressive disorder (MDD) to your patients? How much do bedside manners really matter to the treatment plan? This session will discuss the trending topic of establishing the patient-doctor alliance and effective communication. In addition, the changing landscape of the treatment goal and management of MDD will be discussed, as well as practical advice via case studies of MDD management in active adults.

    WATCH NOW
    Pratap Chokka
    Pratap Chokka
    Canada
    Roger McIntyre
    Roger S. McIntyre
    Canada
  • RECORDED

    The art of disclosing depression to your patients - Focus on depression in older population

    Major depressive disorder (MDD) in the elderly is often accompanied with other chronic comorbidities. The treatment plan is hence complicated by polypharmacy with potential drug-drug interactions, which is further compounded by changing pharmacokinetics as we age. This session will delve into the management of MDD in elderly patients, with these important considerations in mind. The speakers will also discuss prescribing practicalities in the form of case studies in this population.

    WATCH NOW
    Pratap Chokka
    Pratap Chokka
    Canada
    Roger McIntyre
    Roger S. McIntyre
    Canada